Radiofrequency treatment for COPD using a breathing tube
Part of Lungs & breathing clinical trials.
This trial tests whether a special radiofrequency treatment delivered through a bronchoscope (a thin camera tube) is safe and works better than standard care for people with COPD. It focuses on people with moderate-to-severe COPD symptoms who can follow study visits and tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 40 to 75 years
- Have COPD confirmed by breathing tests: FEV1/FVC below 70% after using an inhaler, with FEV1 between 20% and 60% of predicted (and special breathing-blood gas rules if FEV1 is below 30%)
- Have ongoing symptoms: COPD Assessment Test (CAT) score 10 or higher, or shortness of breath score (mMRC) 2 or higher
- Do not smoke for at least 2 months before joining and agree not to smoke during the study
- Have done a formal pulmonary (lung) rehabilitation program at least 3 months ago (or agree to continue a maintenance program through follow-up)
- Have been on standard COPD medicines for at least 12 months and your oxygen level is okay (resting SpO2 89% or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
This trial tests a new bronchoscopy treatment for people with chronic obstructive pulmonary disease (COPD) who have had flare-ups. It aims to find if this treatment can help reduce symptoms and improve quality of life.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This trial tests a procedure called Endobronchial Thermal Liquid Ablation (ETLA) that uses heated liquid to treat severe emphysema. It is for people with COPD who have very low lung function and shortness of breath, and who have not been able to get relief from other treatments.
This trial tests a portable “positive pressure” breathing device in people with severe COPD to see how well it works and whether it’s safe. It may help if you have trouble breathing and meet the device and health requirements.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.